Teva Pharmaceutical Industries Limited (TEVA)
USD 13.6
(1.04%)
USD 13.6
(1.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 15.84 Billion USD | 6.16% |
| 2022 | 14.92 Billion USD | -6.0% |
| 2021 | 15.87 Billion USD | -4.68% |
| 2020 | 16.65 Billion USD | -1.36% |
| 2019 | 16.88 Billion USD | -10.43% |
| 2018 | 18.85 Billion USD | -15.77% |
| 2017 | 22.38 Billion USD | 2.2% |
| 2016 | 21.9 Billion USD | 11.45% |
| 2015 | 19.65 Billion USD | -3.06% |
| 2014 | 20.27 Billion USD | -0.21% |
| 2013 | 20.31 Billion USD | -0.01% |
| 2012 | 20.31 Billion USD | 10.95% |
| 2011 | 18.31 Billion USD | 13.59% |
| 2010 | 16.12 Billion USD | 15.99% |
| 2009 | 13.89 Billion USD | 25.39% |
| 2008 | 11.08 Billion USD | 17.83% |
| 2007 | 9.4 Billion USD | 11.89% |
| 2006 | 8.4 Billion USD | 60.14% |
| 2005 | 5.25 Billion USD | 9.41% |
| 2004 | 4.79 Billion USD | 46.47% |
| 2003 | 3.27 Billion USD | 30.09% |
| 2002 | 2.51 Billion USD | 21.24% |
| 2001 | 2.07 Billion USD | 18.72% |
| 2000 | 1.74 Billion USD | 36.45% |
| 1999 | 1.28 Billion USD | 14.92% |
| 1998 | 1.11 Billion USD | -0.09% |
| 1997 | 1.11 Billion USD | 17.1% |
| 1996 | 953.8 Million USD | 42.85% |
| 1995 | 667.7 Million USD | 13.61% |
| 1994 | 587.7 Million USD | 17.07% |
| 1993 | 502 Million USD | 23.43% |
| 1992 | 406.7 Million USD | 24.34% |
| 1991 | 327.1 Million USD | -0.58% |
| 1990 | 329 Million USD | 17.04% |
| 1989 | 281.1 Million USD | 33.16% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.83 Billion USD | -14.02% |
| 2024 Q2 | 4.16 Billion USD | 8.61% |
| 2023 Q2 | 3.87 Billion USD | 5.93% |
| 2023 Q1 | 3.66 Billion USD | -5.74% |
| 2023 FY | 15.84 Billion USD | 6.16% |
| 2023 Q4 | 4.45 Billion USD | 15.77% |
| 2023 Q3 | 3.85 Billion USD | -0.72% |
| 2022 Q3 | 3.59 Billion USD | -5.02% |
| 2022 Q1 | 3.66 Billion USD | -10.71% |
| 2022 FY | 14.92 Billion USD | -6.0% |
| 2022 Q2 | 3.78 Billion USD | 3.39% |
| 2022 Q4 | 3.88 Billion USD | 8.04% |
| 2021 Q3 | 3.88 Billion USD | -0.61% |
| 2021 FY | 15.87 Billion USD | -4.68% |
| 2021 Q2 | 3.91 Billion USD | -1.81% |
| 2021 Q4 | 4.1 Billion USD | 5.51% |
| 2021 Q1 | 3.98 Billion USD | -10.56% |
| 2020 FY | 16.65 Billion USD | -1.36% |
| 2020 Q3 | 3.97 Billion USD | 2.79% |
| 2020 Q4 | 4.45 Billion USD | 11.92% |
| 2020 Q2 | 3.87 Billion USD | -11.18% |
| 2020 Q1 | 4.35 Billion USD | -2.48% |
| 2019 Q2 | 4.33 Billion USD | 0.98% |
| 2019 FY | 16.88 Billion USD | -10.43% |
| 2019 Q1 | 4.29 Billion USD | -5.79% |
| 2019 Q3 | 4.26 Billion USD | -1.68% |
| 2019 Q4 | 4.46 Billion USD | 4.78% |
| 2018 FY | 18.85 Billion USD | -15.77% |
| 2018 Q1 | 5.06 Billion USD | -7.22% |
| 2018 Q2 | 4.7 Billion USD | -7.19% |
| 2018 Q4 | 4.55 Billion USD | 0.66% |
| 2018 Q3 | 4.52 Billion USD | -3.66% |
| 2017 Q2 | 5.68 Billion USD | 0.99% |
| 2017 Q4 | 5.45 Billion USD | -2.69% |
| 2017 Q3 | 5.61 Billion USD | -1.34% |
| 2017 FY | 22.38 Billion USD | 2.2% |
| 2017 Q1 | 5.63 Billion USD | -13.28% |
| 2016 FY | 21.9 Billion USD | 11.45% |
| 2016 Q1 | 4.81 Billion USD | -1.45% |
| 2016 Q2 | 5.03 Billion USD | 4.74% |
| 2016 Q3 | 5.56 Billion USD | 10.42% |
| 2016 Q4 | 6.49 Billion USD | 16.7% |
| 2015 Q4 | 4.88 Billion USD | 1.2% |
| 2015 FY | 19.65 Billion USD | -3.06% |
| 2015 Q3 | 4.82 Billion USD | -2.88% |
| 2015 Q2 | 4.96 Billion USD | -0.32% |
| 2015 Q1 | 4.98 Billion USD | -3.6% |
| 2014 Q3 | 5.05 Billion USD | 0.26% |
| 2014 FY | 20.27 Billion USD | -0.21% |
| 2014 Q1 | 5 Billion USD | -7.9% |
| 2014 Q2 | 5.04 Billion USD | 0.88% |
| 2014 Q4 | 5.16 Billion USD | 2.17% |
| 2013 Q3 | 5.05 Billion USD | 2.74% |
| 2013 FY | 20.31 Billion USD | -0.01% |
| 2013 Q1 | 4.9 Billion USD | -6.63% |
| 2013 Q2 | 4.92 Billion USD | 0.47% |
| 2013 Q4 | 5.43 Billion USD | 7.33% |
| 2012 Q1 | 5.1 Billion USD | -10.11% |
| 2012 Q4 | 5.24 Billion USD | 5.57% |
| 2012 Q3 | 4.97 Billion USD | -0.44% |
| 2012 Q2 | 4.99 Billion USD | -2.12% |
| 2012 FY | 20.31 Billion USD | 10.95% |
| 2011 FY | 18.31 Billion USD | 13.59% |
| 2011 Q4 | 5.67 Billion USD | 30.66% |
| 2011 Q1 | 4.08 Billion USD | -7.65% |
| 2011 Q2 | 4.21 Billion USD | 3.24% |
| 2011 Q3 | 4.34 Billion USD | 3.13% |
| 2010 Q1 | 3.65 Billion USD | -3.92% |
| 2010 FY | 16.12 Billion USD | 15.99% |
| 2010 Q4 | 4.41 Billion USD | 3.95% |
| 2010 Q3 | 4.25 Billion USD | 11.84% |
| 2010 Q2 | 3.8 Billion USD | 4.02% |
| 2009 Q2 | 3.4 Billion USD | 8.04% |
| 2009 Q1 | 3.14 Billion USD | 10.5% |
| 2009 FY | 13.89 Billion USD | 25.39% |
| 2009 Q3 | 3.55 Billion USD | 4.41% |
| 2009 Q4 | 3.8 Billion USD | 7.1% |
| 2008 Q2 | 2.82 Billion USD | 9.76% |
| 2008 Q4 | 2.84 Billion USD | 0.21% |
| 2008 FY | 11.08 Billion USD | 17.83% |
| 2008 Q1 | 2.57 Billion USD | -0.16% |
| 2008 Q3 | 2.84 Billion USD | 0.67% |
| 2007 Q4 | 2.57 Billion USD | 8.88% |
| 2007 Q1 | 2.08 Billion USD | -8.67% |
| 2007 FY | 9.4 Billion USD | 11.89% |
| 2007 Q2 | 2.38 Billion USD | 14.71% |
| 2007 Q3 | 2.36 Billion USD | -0.84% |
| 2006 Q3 | 2.28 Billion USD | 5.22% |
| 2006 Q1 | 1.67 Billion USD | 19.38% |
| 2006 FY | 8.4 Billion USD | 60.14% |
| 2006 Q4 | 2.27 Billion USD | -0.36% |
| 2006 Q2 | 2.17 Billion USD | 29.89% |
| 2005 Q1 | 1.3 Billion USD | -1.35% |
| 2005 Q4 | 1.4 Billion USD | 6.35% |
| 2005 Q3 | 1.31 Billion USD | 7.34% |
| 2005 Q2 | 1.22 Billion USD | -5.95% |
| 2005 FY | 5.25 Billion USD | 9.41% |
| 2004 Q2 | 1.17 Billion USD | 11.78% |
| 2004 FY | 4.79 Billion USD | 46.47% |
| 2004 Q4 | 1.32 Billion USD | 6.05% |
| 2004 Q3 | 1.24 Billion USD | 6.03% |
| 2004 Q1 | 1.05 Billion USD | 11.72% |
| 2003 Q1 | 757.4 Million USD | -1.66% |
| 2003 Q4 | 942 Million USD | 15.92% |
| 2003 FY | 3.27 Billion USD | 30.09% |
| 2003 Q3 | 812.6 Million USD | 6.31% |
| 2003 Q2 | 764.4 Million USD | 0.92% |
| 2002 Q3 | 631.3 Million USD | 10.37% |
| 2002 Q2 | 572 Million USD | 4.93% |
| 2002 Q4 | 770.2 Million USD | 22.0% |
| 2002 Q1 | 545.1 Million USD | -3.87% |
| 2002 FY | 2.51 Billion USD | 21.24% |
| 2001 Q1 | 490.92 Million USD | -5.31% |
| 2001 Q3 | 505.7 Million USD | -1.54% |
| 2001 Q2 | 513.59 Million USD | 4.62% |
| 2001 FY | 2.07 Billion USD | 18.72% |
| 2001 Q4 | 567.07 Million USD | 12.14% |
| 2000 Q1 | 337.33 Million USD | -11.21% |
| 2000 FY | 1.74 Billion USD | 36.45% |
| 2000 Q3 | 450.05 Million USD | 1.36% |
| 2000 Q4 | 518.47 Million USD | 15.2% |
| 2000 Q2 | 443.99 Million USD | 31.62% |
| 1999 Q2 | 293.7 Million USD | 2.12% |
| 1999 Q1 | 287.6 Million USD | -3.13% |
| 1999 Q4 | 379.9 Million USD | 18.31% |
| 1999 FY | 1.28 Billion USD | 14.92% |
| 1999 Q3 | 321.1 Million USD | 9.33% |
| 1998 Q1 | 268.6 Million USD | -7.98% |
| 1998 FY | 1.11 Billion USD | -0.09% |
| 1998 Q2 | 247.1 Million USD | -8.0% |
| 1998 Q3 | 303.3 Million USD | 22.74% |
| 1998 Q4 | 296.9 Million USD | -2.11% |
| 1997 Q2 | 270.7 Million USD | 1.16% |
| 1997 FY | 1.11 Billion USD | 17.1% |
| 1997 Q3 | 286.7 Million USD | 5.91% |
| 1997 Q4 | 291.9 Million USD | 1.81% |
| 1997 Q1 | 267.6 Million USD | -3.64% |
| 1996 Q4 | 277.7 Million USD | 17.37% |
| 1996 Q3 | 236.6 Million USD | -5.44% |
| 1996 Q2 | 250.2 Million USD | 32.17% |
| 1996 Q1 | 189.3 Million USD | -1.87% |
| 1996 FY | 953.8 Million USD | 42.85% |
| 1995 Q1 | 152.7 Million USD | -4.92% |
| 1995 Q3 | 165.3 Million USD | 5.42% |
| 1995 Q2 | 156.8 Million USD | 2.69% |
| 1995 FY | 667.7 Million USD | 13.61% |
| 1995 Q4 | 192.9 Million USD | 16.7% |
| 1994 Q1 | 136.7 Million USD | 4.11% |
| 1994 FY | 587.7 Million USD | 17.07% |
| 1994 Q4 | 160.6 Million USD | 11.92% |
| 1994 Q3 | 143.5 Million USD | -2.31% |
| 1994 Q2 | 146.9 Million USD | 7.46% |
| 1993 Q4 | 131.3 Million USD | 3.22% |
| 1993 Q3 | 127.2 Million USD | 1.76% |
| 1993 Q1 | 118.4 Million USD | -10.24% |
| 1993 FY | 502 Million USD | 23.43% |
| 1993 Q2 | 125 Million USD | 5.57% |
| 1992 Q4 | 131.9 Million USD | 41.83% |
| 1992 Q2 | 93 Million USD | 0.11% |
| 1992 Q1 | 92.9 Million USD | 12.33% |
| 1992 Q3 | 93 Million USD | 0.0% |
| 1992 FY | 406.7 Million USD | 24.34% |
| 1991 Q2 | 77.8 Million USD | -10.88% |
| 1991 Q4 | 82.7 Million USD | 5.08% |
| 1991 Q1 | 87.3 Million USD | -37.6% |
| 1991 Q3 | 78.7 Million USD | 1.16% |
| 1991 FY | 327.1 Million USD | -0.58% |
| 1990 FY | 329 Million USD | 17.04% |
| 1990 Q1 | 65.7 Million USD | -22.98% |
| 1990 Q2 | 69.6 Million USD | 5.94% |
| 1990 Q3 | 62.6 Million USD | -10.06% |
| 1990 Q4 | 139.9 Million USD | 123.48% |
| 1989 Q3 | 63.8 Million USD | -7.27% |
| 1989 Q2 | 68.8 Million USD | 0.88% |
| 1989 Q1 | 68.2 Million USD | 2.71% |
| 1989 Q4 | 85.3 Million USD | 33.7% |
| 1989 FY | 281.1 Million USD | 33.16% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.39 Billion USD | -562.013% |
| Bausch Health Companies Inc. | 8.75 Billion USD | -80.952% |
| Catalent, Inc. | 4.38 Billion USD | -261.698% |
| Emergent BioSolutions Inc. | 1.04 Billion USD | -1410.15% |
| Elanco Animal Health Incorporated | 4.41 Billion USD | -258.75% |
| Perrigo Company plc | 4.65 Billion USD | -240.364% |
| Zoetis Inc. | 8.54 Billion USD | -85.463% |